XML 78 R65.htm IDEA: XBRL DOCUMENT
v3.23.2

Investments in Other Entities - Equity Method (Details) $ in Thousands | 12 Months Ended
--- | ---
Dec. 31, 2022 USD ($)
Equity Method Investments [Roll Forward] |
Beginning Balance | $ 41,715
Allocation of Income (Loss) | 5,622
Funding reclassified to loan receivable | (2,125)
Funding | 2,105
Entity Consolidated | (6,418)
Distribution | (600)
Ending Balance | 40,299
LaSalle Medical Associates – IPA Line of Business |
Equity Method Investments [Roll Forward] |
Beginning Balance | 3,034
Allocation of Income (Loss) | 4,775
Funding reclassified to loan receivable | (2,125)
Funding | 0
Entity Consolidated | 0
Distribution | 0
Ending Balance | 5,684
Pacific Medical Imaging & Oncology Center, Inc. |
Equity Method Investments [Roll Forward] |
Beginning Balance | 1,719
Allocation of Income (Loss) | 159
Funding reclassified to loan receivable | 0
Funding | 0
Entity Consolidated | 0
Distribution | 0
Ending Balance | 1,878
531 W. College, LLC – related party |
Equity Method Investments [Roll Forward] |
Beginning Balance | 17,230
Allocation of Income (Loss) | (619)
Funding reclassified to loan receivable | 0
Funding | 670
Entity Consolidated | 0
Distribution | 0
Ending Balance | 17,281
One MSO, LLC — related party |
Equity Method Investments [Roll Forward] |
Beginning Balance | 2,910
Allocation of Income (Loss) | 408
Funding reclassified to loan receivable | 0
Funding | 0
Entity Consolidated | 0
Distribution | (600)
Ending Balance | 2,718
Tag-6 Medical Investment Group, LLC — related party |
Equity Method Investments [Roll Forward] |
Beginning Balance | 4,830
Allocation of Income (Loss) | 153
Funding reclassified to loan receivable | 0
Funding | 1,435
Entity Consolidated | (6,418)
Distribution | 0
Ending Balance | 0
CAIPA MSO, LLC |
Equity Method Investments [Roll Forward] |
Beginning Balance | 11,992
Allocation of Income (Loss) | 746
Funding reclassified to loan receivable | 0
Funding | 0
Entity Consolidated | 0
Distribution | 0
Ending Balance | $ 12,738

X
- Definition Equity Method Investment, Funding Reclassified to Loan Receivable + References No definition available. + Details
Name: | ameh_EquityMethodInvestmentFundingReclassifiedToLoanReceivable
Namespace Prefix: | ameh_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Equity Method Investment, Investment In Period + References No definition available. + Details
Name: | ameh_EquityMethodInvestmentInvestmentInPeriod
Namespace Prefix: | ameh_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Equity Method Investments, Consolidated + References No definition available. + Details
Name: | ameh_EquityMethodInvestmentsConsolidated
Namespace Prefix: | ameh_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Equity Method Investments, Contribution + References No definition available. + Details
Name: | ameh_EquityMethodInvestmentsContribution
Namespace Prefix: | ameh_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Equity Method Investments + References No definition available. + Details
Name: | ameh_EquityMethodInvestmentsRollForward
Namespace Prefix: | ameh_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of the entity's equity method investment which has been sold. + References No definition available. + Details
Name: | us-gaap_EquityMethodInvestmentSoldCarryingAmount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 45 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(10)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599 + Details
Name: | us-gaap_EquityMethodInvestments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ameh_LasalleMedicalAssociatesIpaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ameh_PacificMedicalImagingAndOncologyCenterIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ameh_FiveThreeOneW.CollegeLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ameh_OneMSOLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ameh_Tag6MedicalInvestmentGroupLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ameh_CAIPAMSOMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |